RedHill Biopharma regains Nasdaq stockholders' equity compliance
Source: SeekingAlpha
2025-12-01 14:05:40 ET
More on RedHill
Read the full article on Seeking Alpha
For further details see:
RedHill Biopharma regains Nasdaq stockholders’ equity compliance
Redhill Biopharma Ltd.
NASDAQ: RDHL
RDHL Trading
-0.01% G/L:
$0.92 Last:
6,488 Volume:
$0.9395 Open:
RDHL Latest News
January 05, 2026 07:00:00 am
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
December 15, 2025 07:00:00 am
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
December 01, 2025 07:00:00 am
RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement
